Latest GM & Biosafety Resources

Cliquez ici pour le français The ACB shares this research paper with you, of the wave of ‘Trojan horse’ second-generation genetic engineering strategies targeted at, inter alia, malaria in Africa, at a time when the COVID-19 crisis is fracturing the myth that global health expertise is the domain of North America and Europe. Global health […]

A heated public debate on genetically modified organisms (GMOs) ensued during a seminar organised by MVIWATA – a network of smallholder farmers – in Morogoro, Tanzania. The meeting took place on 12 May 2018 and was attended by more than a hundred people, including parliamentarians and high-level government officials. The event, which was intended only […]

The Water Efficient Maize for Africa (WEMA) project promises to develop drought tolerance in maize for the benefit of small holder farmers, but is really a project designed to facilitate the spread of hybrid and genetically modified (GM) maize varieties on the continent. WEMA involves five African countries: Kenya, Mozambique, South Africa, Tanzania and Uganda. […]

The African Centre for Biodiversity (ACB) has today released a new report titled, GM and seed industry eye Africa’s lucrative cowpea seed markets: The political economy of cowpea in Nigeria, Burkina Faso, Ghana and Malawi. The report shows a strong interest by the seed industry in commercialising cowpea seed production and distribution in West Africa, […]

BOLETÍN DE PRENSA Grupo ETC, Centro Africano para la Bioseguridad, FoodMattersZimbabwe y CTDT El Centro Africano para la Bioseguridad (ACB, African Center for Biosafety) manifiesta su alarma ante el hecho de que las autoridades sudafricanas dieron luz verde a la exportación de más de 25 mil toneladas de maíz transgénico hacia Zimbawe. Es la primera […]

The ACB is deeply concerned by the news that the South African GMO authorities have permitted over 25,000 tons of GM maize to be exported to Zimbabwe. This is the first time that South African GM maize grains have been commercially exported to our neighbor north of the Limpopo, and adds to a growing list […]

The Africa Centre for Biosafety (ACB) has dismissed the findings of the biotechnology industry’s flagship annual report, published by the GM industry funded ‘NGO’, the International Service for the Acquisition of Agri-biotech Applications (ISAAA), as mischievous and erroneous. According to the report, South Africa’s GM crop area increased by a record 26% or 600,000 hectares […]

The African Centre for Biosafety (ACB) condemns the decision by the Minister of Agriculture, Fisheries and Forestry to allow GM cassava field trials to go ahead in South Africa. This despite SA’s GMO regulatory body rejecting such trials more than three years ago. The field trials involve cassava genetically modified to control starch content. On […]

Stacked GMOs are those containing more than one gene genetically engineered into a crop plant. A controversial stacked GMO, Smarstax containing 8 such genetically engineered genes, was commercially approved in the US, Canada, Japan and South Korea during 2009. Stacked gene varieties are highly complex, posing new biosafety risks that outpace the capacity of regulatory […]

Uncertainty and apprehension often afford opportunity to the cunning. This is certainly the case with climate change. The multinational seed and agrochemical industry see climate change as a means by which to further penetrate African agricultural markets by rhetorically positioning itself, even if implausibly, as having the solution to widespread climate concerns. Their so-called “final […]

We have in the past, commented on several drafts of Uganda’s biosafety law and will not repeat the issues canvassed therein regarding the role and influence of the United States. We have been requested by civil society groups to comment on the National Biotechnology Safety Bill, 2008, approved by Uganda’s Cabinet during April 2008. Uganda […]

Evidently influenced by the UNEP-GEF Biosafety Project, the Biosafety Bill has been drafted principally to implement the Biosafety Protocol verbatim, and in so doing, perpetuates some of the weaknesses and deficiencies of the Biosafety Protocol. For instance, the scope of the Biosafety Bill is predicated on the scope of the Biosafety Protocol where the risks […]